Article
No association between the<i>Plasmodium vivax crt-o</i>MS334 or In9<i>pvcrt</i>polymorphisms and chloroquine failure in a clinical cohort from Malaysia
2022-12-01
Abstract excerpt
Increasing reports of resistance to a frontline malaria blood-stage treatment, chloroquine (CQ), raise concerns for the elimination of Plasmodium vivax . The absence of an effective molecular marker of CQ resistance in P. vivax greatly constrains surveillance of this emerging threat. A recent genetic cross between CQ sensitive (CQS) and CQ resistant (CQR) NIH-1993 strains of P. vivax linked a moderate CQR phenotyp...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d5838a4c-2cc4-5e2c-a339-cd92f74a6af0
- DOI
- 10.1101/2022.11.30.22282917
